Nilanjan Adhikari
Also known as: Adhikari N
Jadavpur University Department of Pharmaceutical Technology
0000-0001-5523-7716
About
Dr. Nilanjan Adhikari is an assistant professor in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. He completed his B.Pharm. (2007), M.Pharm. (2009), and Ph.D. (2018) from Jadavpur University, Kolkata. His research area includes the development of anticancer small molecules, especially inhibitors of metalloenzymes. He is also working on molecular modeling of different bioactive compounds through rigorous computational techniques including QSAR and machine learning approaches.
Dr. Adhikari is an editor of Bioorganic Chemistry (Elsevier) Since May, 2026. He has published more than 150 articles in different international peer-reviewed journals as well as scientific book chapters (Scopus h-index: 31; Google Scholar i10-index: 110). He is also a reviewer of various reputed international journals published by Elsevier, ACS, Springer Nature, Wiley, and Taylor and Francis. Dr. Adhikari has been recognized among the world’s Top 2% scientists as per the "Updated science-wide author databases of standardized citation indicators" (Contributor: John P.A. Ioannidis) for the last four years.
Employment
-
Jadavpur University Department of Pharmaceutical Technology Assistant Professor2021 - Present
Education
-
Jadavpur University Department of Pharmaceutical Technology Ph. D.2011 - Present
-
Jadavpur University Department of Pharmaceutical Technology M. Pharm.2007 - 2009
-
Jadavpur University Department of Pharmaceutical Technology B. Pharm.2003 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (128)
- Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors Save
- Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions Save
- PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies Save
- Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis Save
- Fosamprenavir and Tirofiban to combat COPD and cancer: A drug repurposing strategy integrating virtual screening, MD simulation, and DFT studies Save
- Synthesis, biological assessment, and in silico binding mode interaction analyses and DFT studies of biphenylsulfonamide-based potent MMP-2 inhibitors effective against chronic myeloid leukemia Save
- A combined ligand-based and structure-based in silico molecular modeling approach to pinpoint the key structural attributes of hydroxamate derivatives as promising meprin β inhibitors Save
- An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies Save
- Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies Save
- Fragment-based structural exploration and chemico-biological interaction study of HDAC3 inhibitors through non-linear pattern recognition, chemical space, and binding mode of interaction analysis Save